NIAID:  In Vitro Assessments of Antimicrobial Activity
RFP-NIAID-DMID-NIHAI2017091
Response date Jan. 26, 2018

https://www.fbo.gov/index?s=opportunity&mode=form&id=3d3fab0dc4550fb6ec2...

The current solicitation addresses a critical stage in this pipeline by providing an efficient means to assess the therapeutic potential of compounds through in vitro testing. The overarching goal of the In Vitro Assessments of Antimicrobial Activity program is to provide a broad and flexible range of in vitro assessment capabilities to the extramural research community to evaluate promising candidate countermeasures against the more than 270 pathogens, toxins, and vectors (PTVs) that are within the purview of DMID. In vitro assay capabilities include: product screening, assay development, and development of improved systems for culturing difficult to grow pathogens in vitro. These capabilities will allow the NIAID to respond to changing priorities as scientific and public health needs shift, including rapid responses to public health emergencies.